iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Autor: de Jong, Wesley, Aerts, Joeri, Gatell, José M., Honrado, Ángel, Buyze, Jozefien, Florence, Eric, van Gorp, Eric, Van Meirvenne, Sonja, Leal, Lorna, Mothe, Beatriz, Thielemans, Kris, Heirman, Carlo, García Alcaide, Felipe, Gruters, Rob, Pannus, Pieter, Boers, Patrick, Arnaiz Gargallo, Juan Alberto, Plana Prades, Montserrat, Guardo, Alberto C., Koopmans, Marion, Maleno, María José, Vanham, Guido, Lungu, Cynthia, Moltó, José, Salgado, Maria, Heyndrickx, Leo, Graupera, Anna, Scheuer, Rachel, Allard, Sabine, Tjok, Patrick, Brander, Christian, Martínez Picado, Javier, Olvera, Alex, Rosas Umbert, Miriam, Moron, Sara, Molto, Jose, López, Miriam

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Trials
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Trials, 20:361. BioMed Central Ltd.

Background: HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f66685f1ba09fe6296e6a5f0d83ecc
http://hdl.handle.net/2445/179237

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Retrovirally Transduced Bone Marrow-Derived Dendritic Cells Require CD4+ T Cell Help to Elicit Protective and Therapeutic Antitumor Immunity

Autor: De Veerman, Marijke, Heirman, Carlo, Van Meirvenne, Sonja, Devos, Sophie, Corthals, Jurgen, Moser, M., Thielemans, Kris

Publikováno v: The Journal of Immunology. 162:144-151

It has been extensively documented that murine dendritic cells loaded with tumor-associated Ag (TAA)-derived peptides or protein can prime Ag-specific CD8+ cytotoxic T cells in vivo and can elicit Ag-specific immunity. Optimal presentation of TAA mig

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb05d784701f51a34638ccaa4b697113
https://doi.org/10.4049/jimmunol.162.1.144

Fas deficient dendritic cells transduced with FasL induce strong allogeneic T cell responses in vivo

Autor: Flamand, V., Buonocore, S., Paulart, F., Braun, M., Le Moine, A., Van Meirvenne, Sonja, Thielemans, Kristiaan, Goldman, Michel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::c4cb736f8508b87420f2d70c163eb0e4
https://biblio.vub.ac.be/vubir/fas-deficient-dendritic-cells-transduced-with-fasl-induce-strong-allogeneic-t-cell-responses-in-vivo(b33bb7d0-879f-406e-bb89-6043e7becdec).html

Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human disease

Autor: Zhu, D., Van Arkel, C., King, C.a., Van Meirvenne, Sonja, De Greef, Catherine, Thielemans, Kris, Radl, J., Stevenson, F.k.

Publikováno v: Immunology, 93, 162-170. Wiley-Blackwell Publishing Ltd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ad4a319d598bc6f2b8e5deb43403532e
https://pure.eur.nl/en/publications/859fb114-d161-40c4-af29-ab5b8d5866ea